Nabriva Therapeutics plc Quarterly Costs and Expenses in USD from Q1 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Nabriva Therapeutics plc quarterly/annual Costs and Expenses history and growth rate from Q1 2018 to Q2 2023.
  • Nabriva Therapeutics plc Costs and Expenses for the quarter ending June 30, 2023 was $14.3M, a 27.2% decline year-over-year.
  • Nabriva Therapeutics plc Costs and Expenses for the twelve months ending June 30, 2023 was $83.6M, a 3.21% increase year-over-year.
  • Nabriva Therapeutics plc annual Costs and Expenses for 2022 was $92.4M, a 19.4% increase from 2021.
  • Nabriva Therapeutics plc annual Costs and Expenses for 2021 was $77.4M, a 8.81% increase from 2020.
  • Nabriva Therapeutics plc annual Costs and Expenses for 2020 was $71.2M, a 20% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $83.6M $14.3M -$5.32M -27.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-10-19
Q1 2023 $88.9M $16.1M -$3.51M -17.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $92.4M $32.9M +$10.8M +48.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 $81.7M $20.4M +$679K +3.45% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $81M $19.6M -$35K -0.18% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-19
Q1 2022 $81M $19.6M +$3.6M +22.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $77.4M $22.1M +$1.42M +6.84% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $76M $19.7M +$5.17M +35.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $70.8M $19.6M +$4.69M +31.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $66.2M $16M -$5M -23.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $71.2M $20.7M -$1.68M -7.48% Oct 1, 2020 Dec 31, 2020 10-K 2023-04-17
Q3 2020 $72.8M $14.5M -$9.61M -39.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $82.4M $14.9M -$6.56M -30.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $89M $21M +$30K +0.14% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $89M $22.4M -$9.27M -29.3% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 $98.2M $24.1M -$29.3M -54.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $128M $21.5M +$2.95M +15.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $125M $20.9M +$532K +2.61% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $124M $31.7M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $53.4M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 $18.6M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 $20.4M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.